Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity

Search results

• Active

  Harnessing lipid transport pathways for enhanced drug delivery

  Porter, C.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/20 → 31/12/25

  Project: Research

• Finished

  Drug targeting to sites of lymph-adipose interaction to transform the treatment of disease

  Trevaskis, N., Porter, C., Watt, M. & Creek, D.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/16 → 31/12/18

  Project: Research

• ARC Centre of Excellence in Convergent Bio-Nano Science and Technology

  Davis, T., Boyd, B., Bunnett, N., Porter, C., Caruso, F., Kent, S., Thordarson, P., Kearnes, M., Gooding, J., Kavallaris, M., Thurecht, K., Whittaker, A. K., Parton, R., Corrie, S. R., Johnston, A., McGhee, J., Greguric, I. D., Stevens, M. M., Lewis, J. S., Lee, D. S., Alexander, C., Dawson, K., Hawker, C., Haddleton, D., Thierry, B., Prestidge, C. A., Meyer, A., Jones-Jayasinghe, N., Voelcker, N., Nann, T. & McLean, K.

  Australian Research Council (ARC), Monash University, University of Melbourne, University of New South Wales (UNSW), University of Queensland , University of South Australia, Monash University – Internal Faculty Contribution, University of Wisconsin Madison, Memorial Sloan Kettering Cancer Center, University of California System, University College Dublin, Imperial College London, University of Warwick, Sungkyunkwan University, Australian Nuclear Science and Technology Organisation (ANSTO) , University of Nottingham

  30/06/14 → 29/06/21

  Project: Research